Myeloma breakthrough? study tests if patients can ditch lifelong drugs
NCT ID NCT05866757
First seen Mar 08, 2026 · Last updated May 22, 2026 · Updated 8 times
Summary
This study looks at whether people with multiple myeloma who have achieved a very deep remission (called MRD-negative) and have been on maintenance therapy for at least two years can stop that therapy without their cancer coming back. Researchers will follow 70 participants for up to two years to see how many remain in remission. The goal is to understand if stopping treatment is safe for this specific group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cork University Hospital
RECRUITINGCork, Ireland, Ireland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.